Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: RESPONSE TO SGX QUERIES | 190 | SGX Company Announcements | ||
29.03. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
29.03. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | 1 | SGX Company Announcements | ||
29.03. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ANNOUNCEMENT ON CONTINUOUS RISK ASSESSMENT REPORT OF TPGF | 1 | SGX Company Announcements | ||
29.03. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE DEPOSIT OF NET PROCEEDS AND THE USE OF NET PROCEEDS | 1 | SGX Company Announcements | ||
29.03. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS | 1 | SGX Company Announcements | ||
05.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: WAIVER::WAIVER ANNOUNCEMENT | 2 | SGX Company Announcements | ||
09.01. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT | 3 | SGX Company Announcements | ||
26.12.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE 5TH PROPOSED REPURCHASE | - | SGX Company Announcements | ||
26.12.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE 1ST EGM OF THE COMPANY FOR FY2023 HELD ON 28 NOVEMBER 2023 | - | SGX Company Announcements | ||
19.12.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: INTERESTED PERSON TRANSACTION::PROPOSED ENTRY INTO SERVICE AGREEMENT WITH TIANJIN PHARMACEUTICAL GROUP MARKETING CO., LTD. | 1 | SGX Company Announcements | ||
19.12.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: INTERESTED PERSON TRANSACTION::PROPOSED ENTRY INTO CONSTRUCTION CONTRACTS WITH TIANJIN PHARMACEUTICAL DESIGN INSTITUTE CO., LTD. | 1 | SGX Company Announcements | ||
19.12.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 9TH BOARD MEETING FOR FY2023 | 1 | SGX Company Announcements | ||
15.12.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT OF THE COMPANY UNDER THE NATIONAL REIMBURSEMENT DRUG LIST | - | SGX Company Announcements | ||
11.12.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | 1 | SGX Company Announcements | ||
28.11.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::CHANGE - ANNOUNCEMENT OF APPOINTMENT | 1 | SGX Company Announcements | ||
28.11.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::CHANGE - ANNOUNCEMENT OF CESSATION | 1 | SGX Company Announcements | ||
28.11.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: EXTRAORDINARY/ SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
23.11.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/ UNITHOLDER(S)::THE FURTHER CHANGE IN THE SHAREHOLDING STRUCTURE OF THE COMPANY S CONTROLLING SHAREHOLDER | 1 | SGX Company Announcements | ||
22.11.23 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE FURTHER CHANGE IN THE SHAREHOLDING STRUCTURE OF THE COMPANY S CONTROLLING SHAREHOLDER | - | SGX Company Announcements |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ASTRAZENECA | 139,80 | +5,43 % | Verhaltene Kauflaune bei Aktie von AstraZeneca plc (64,2491 €) | Wenig Kursbewegung aktuell bei dem Anteilsschein von AstraZeneca plc . Die Aktie notiert derzeit bei 68,39 US-Dollar. Kaum auffällig ist zur Stunde an der Börse der Kurs von AstraZeneca plc . Das Papier... ► Artikel lesen | |
TEVA | 12,050 | -1,23 % | Supreme Court Denies Vanda Pharma' Petition In HETLIOZ Litigation Against Teva, Apotex | PETAH TIKVA (dpa-AFX) - The U.S. Supreme Court denied Vanda Pharmaceuticals Inc.'s (VNDA) petition for a writ of certiorari in its HETLIOZ Abbreviated New Drug Application litigation against... ► Artikel lesen | |
SANOCHEMIA PHARMAZEUTIKA | - | - | Nachlese: Magnus Brunner vs. FMA" EOSS holt nach Sanochemia auch BDI BioEnergy; Bettina Pfluger (Christian Drastil) | Um 12:12 liegt der ATX mit +0.03 Prozent im Plus bei 3452 Punkten (Ultimo 2023: 3435, 0.49% ytd). Topperformer der PIR-Group sind Addiko Bank mit +1.82% auf 15.425 Euro, dahinter DO&CO mit +1.79% auf... ► Artikel lesen | |
XTACY THERAPEUTICS | 0,035 | 0,00 % | Xtacy Therapeutics Corp: Xtacy Therapeutics files fiscal 2023 results | ||
SINOPHARM | 2,620 | +1,83 % | SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE FIRST QUARTER ENDED 31 MARCH ... | ||
CSPC PHARMA | 0,751 | +3,70 % | CSPC Pharmaceutical Group-Aktie kann Vortagsniveau nicht halten (0,686 €) | Im Minus liegt zur Stunde die Aktie der CSPC Pharmaceutical Group . Das Wertpapier kostete zuletzt 0,69 Euro. An der Börse liegt die CSPC Pharmaceutical Group-Aktie aktuell im Minus. Die Aktie verbilligte... ► Artikel lesen | |
TRYP THERAPEUTICS | 0,036 | -5,33 % | CSE Bulletin: Delist - Tryp Therapeutics Inc. (TRYP) | Toronto, Ontario--(Newsfile Corp. - Le 24 avril/April 2024) - Tryp Therapeutics Inc. (the "Issuer") has announced that further to the press release dated February 8, 2024, the shareholders of Exopharm... ► Artikel lesen | |
OPKO HEALTH | 1,159 | +1,22 % | OPKO Health, Inc.: AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV | • Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans• Candidate showed similar half-life to standard monoclonal antibodies... ► Artikel lesen | |
WUXI BIOLOGICS | 1,545 | +0,13 % | Aktie von Wuxi Biologics Cayman: Kurs heute nahezu konstant (1,64 €) | CODE Die Aktie kostete zuletzt 1,64 Euro. Die Wertschätzung der Börsenteilnehmer für der Anteilsschein von Wuxi Biologics Cayman hat sich heute kaum verändert. Das Wertpapier liegt aktuell nur minimal... ► Artikel lesen | |
SHANGHAI FOSUN PHARMACEUTICAL | 1,470 | +4,40 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY | ||
DR REDDYS | 66,00 | 0,00 % | Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution | NEW DELHI (dpa-AFX) - Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level.According to the U.S. Food and... ► Artikel lesen | |
GEDEON RICHTER | 22,840 | 0,00 % | Aktien Osteuropa Schluss: Börsen schließen überwiegend mit Gewinnen | PRAG/BUDAPEST/WARSCHAU (dpa-AFX) - Die wichtigsten Börsen in Mittel- und Osteuropa haben am Donnerstag überwiegend mit Gewinnen schlossen. Lediglich in Budapest ging es nach unten. Am deutlichsten... ► Artikel lesen | |
DMK PHARMACEUTICALS | 0,049 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 2 | The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameLU0102219945 G.SACHS... ► Artikel lesen | |
BAYER | 27,290 | +1,19 % | DAX-Check LIVE: Bayer, Covestro, Munich Re, Sartorius Vz., Siemens, Siemens Energy im Fokus | Der DAX startete gestern einen erneuten Erholungsversuch. Gegen Mittag eroberte er die 17.900 Punkte-Marke zurück. Am Ende des Tages blieb dann aber nicht viel von den Zugewinnen übrig. Er ging lediglich... ► Artikel lesen | |
MERCK KGAA | 149,55 | -1,84 % | Merck: Kursziel 200 Euro bestätigt - Ist das die Einstiegschance? | Merck-Aktien ISIN: DE0006599905 gehören in der vergangenen Handelswoche mit knapp 5 Prozent minus zu den größten Verlierern im DAX. Nach einem Jahreshoch bei 164,85 Euro geht es steil nach unten und... ► Artikel lesen |